Arzeda is a series b startup based in United States. 1 investor tracked.
Based in the United States, Arzeda is a startup. Brouky records 3 investors associated with the company.
Arzeda develops computational protein design technology to create novel enzymes and specialty chemicals for industrial and life sciences applications.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.